Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction - Wikidata - wikimedia - TriplyDB

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

http://www.wikidata.org/entity/Q35121830

about

The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies Reducing myocardial infarct size: challenges and future opportunities Nitrate/Nitrite as Critical Mediators to Limit Oxidative Injury and Inflammation Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies Functional Characterization of the GUCY1A3 Coronary Artery Disease Risk Locus.Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts Dietary Nitrate and the Epidemiology of Cardiovascular Disease: Report From a National Heart, Lung, and Blood Institute Workshop.Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.A 'green' diet-based approach to cardiovascular health? Is inorganic nitrate the answer?Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases.Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.Advances in treatment strategies for ischemia reperfusion injury.It is rocket science - why dietary nitrate is hard to 'beet'! Part I: twists and turns in the realization of the nitrate-nitrite-NO pathway.The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.Combined analysis of the safety of intra-coronary drug delivery during primary percutaneous coronary intervention for acute myocardial infarction: A study of three clinical trials.Remote ischaemic preconditioning suppresses endogenous plasma nitrite during ischaemia-reperfusion: a randomized controlled crossover pilot study.The GTN patch: a simple and effective new approach to cardioprotection?Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites

P2860

Q26747310-79FB5BC5-32B1-4462-87F7-CC162852243E Q26775395-E617EA43-6567-40D9-82F8-8554DCFB5505 Q27021987-73FBF0A7-F5F0-4955-AA59-3E49D1BFC371 Q28078386-D6D9E9A7-6937-4A57-ABA0-7298407E1BD4 Q30252419-107E829E-EDF6-4ED6-AC2F-9B12FC652653 Q33663800-F4AFB068-FB21-4074-A48D-1BC72CF77176 Q37240670-13DBA368-23B9-416A-BC64-C650908518DE Q37738596-739C3CA0-2FF1-4BB2-953A-094EDD8003B0 Q38541215-FC2C1F00-108B-4EDE-8DC0-A6234DEECEFD Q38542449-1B1C60BC-63F6-40BC-B342-34E958B0AC32 Q38563297-0F588DBB-C1D2-46F2-894D-48B73930D1E0 Q38621788-81FAE0AA-86B8-4778-9B91-A8D69282C176 Q38631258-654AE656-367E-4D96-9392-645337069721 Q38690399-17DCCE85-2B93-4318-94C1-3403C1966CDD Q38741877-300EDA4A-468F-4018-B6EE-8E36311081BA Q38880162-463679BE-B10C-468E-A89E-D0285F8B5847 Q43131197-2EA4F2A9-2E9F-4BD5-B294-248E26F3F71F Q53583109-AD229A81-06B7-4415-8FB3-81EB82877FDF Q54429906-91AE2B54-EFDB-4801-AC13-BDDD37A1DAE7 Q58702398-A8650E9A-D5A3-46DA-86CD-F0ECDD7DC031

P2860

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

http://www.wikidata.org/entity/Q35121830

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

@ast

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

@en

type

label

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

@ast

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

@en

prefLabel

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

@ast

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

@en

P1433

Q35121830-9BF3CB5A-A26E-468B-8555-13D7EE9AAE5B

P1476

Q35121830-7AE4208E-27CA-4F41-91AA-4E964D9AAD87

P2093

Q35121830-093B77C4-4F59-4BFA-80DA-C793AE02369D

Q35121830-104830A7-D920-4CC3-AEA7-9265B8DC7120

Q35121830-397AB8D9-E8F4-4FEF-A809-E1B66DEA11A6

Q35121830-6551827A-A963-4714-AAAE-B32E9BC56E13

Q35121830-9B9A7A68-35B6-4EA1-AF20-2DC2707B4270

Q35121830-C8DCDE15-2147-4926-8A5C-186981EBC1B5

Q35121830-DF54541A-3044-45E7-B84F-1FF913FBFC6C

Q35121830-E58AB412-11FD-441A-8740-2BE3CC0D55D7

Q35121830-F7728AA0-A82C-4E2E-A46A-24CC7DCD0E72

P2860

Q35121830-0AA5C038-F68B-4363-98C2-B8CD81EE0BF3

Q35121830-2A2D7217-3CF3-4F8E-B974-7CC43A38721D

Q35121830-2B3E099D-E5BB-4C1F-A2DC-F8E37306C98A

Q35121830-2E8D67F8-95D8-4451-A8AE-5DDD2D74305E

Q35121830-39409FC6-C83B-4F1B-8707-7CE6E3C28820

Q35121830-3DA2DCC9-CCAC-4F7D-A6D5-EB1BCA2B0D8F

Q35121830-4A2ECDDB-C631-49C7-9620-3F56F256052D

Q35121830-53E297C2-1773-44F3-B26A-426AD8CA1FB9

Q35121830-67E9AD2E-E27C-42C4-B571-F8CA2C3D952A

Q35121830-6D01AA28-9EBA-4C0D-8CF5-FE540AD63D26

P304

Q35121830-163BC51A-78BC-44DA-B1BA-97540314CFFA

P31

Q35121830-40A7BF42-8966-4CB6-8CAB-D89D3BDF0505

P356

Q35121830-7CD44962-22BC-4B3B-AC69-523F7334102B

P433

Q35121830-F98D501D-65FC-46DC-9C40-0A684BA6232A

P478

Q35121830-EFF9135C-325E-4875-A50D-C9CCA29E41B5

P50

Q35121830-166E827C-A037-4E53-8060-AC1CC691BB74

Q35121830-5CCEF5AC-E39B-4377-AC08-5DF5A0DFC133

Q35121830-E288A90B-7FE9-4B3C-98F8-117DA7E84E31

P577

Q35121830-5B8DB6D8-BE7C-4D7B-AA78-1D12C8E252E2

P698

Q35121830-471B1C4C-F430-4BB8-9B34-4717934D89F0

P921

Q35121830-58F92268-C8D7-4A40-88B4-3C6EBEF47324

P932

Q35121830-92955B81-8245-460B-8E6E-A55A771FC37D

P356

CIRCRESAHA.116.305082

P1433

Circulation Research

P1476

Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction

@en

P2093

Andrew J Webb

http://www.w3.org/2001/XMLSchema#string

Anthony Mathur

http://www.w3.org/2001/XMLSchema#string

Cyril Pellaton

http://www.w3.org/2001/XMLSchema#string

Krishnaraj Sinha Rathod

http://www.w3.org/2001/XMLSchema#string

Mahesh K Parmar

http://www.w3.org/2001/XMLSchema#string

Mark A Westwood

http://www.w3.org/2001/XMLSchema#string

Mervyn Andiapen

http://www.w3.org/2001/XMLSchema#string

Shanti Velmurugan

http://www.w3.org/2001/XMLSchema#string

Sotiris Antoniou

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

The L-arginine-nitric oxide pathway

Platelet inhibition by nitrite is dependent on erythrocytes and deoxygenation

Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers.

Primary PCI for myocardial infarction with ST-segment elevation.

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)

Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver

Myocardial reperfusion injury.

P304

437-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.116.305082

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Amrita Ahluwalia

P577

2014-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25512434

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

4340586

http://www.w3.org/2001/XMLSchema#string